期刊文献+

儿童垂体柄阻断综合征的临床及基因研究 被引量:3

Childhood pituitary stalk interruption syndrome: a clinical-genetic study
下载PDF
导出
摘要 目的探讨儿童垂体柄阻断综合征的临床表现及基因突变类型。方法选取2016年1月至2018年3月首都儿科研究所附属儿童医院内分泌科收治的垂体柄阻断综合征患儿16例,回顾性分析患儿的临床表现,并采用全外显子测序技术进行基因学检测,根据美国医学遗传学与基因组学学会(American College of Medical Genetics and Genomics,ACMG)指南对其致病性进行分析。结果共纳入16例垂体柄阻断综合征患儿,诊断年龄为1.7~16.2岁,男11例,女5例;4例有臀位产病史,11例以"身高增长缓慢"就诊,4例以"反复无热抽搐"为主要表现。16例患儿均为生长激素缺乏,其中15例有中枢性甲状腺功能减退,11例继发性肾上腺皮质功能不全。2例发现致病性突变,其中1例为4.9岁男孩,为ROBO1基因c.1690C>T(p.Pro564Ser)杂合突变,1例为12.3岁女孩,为HS6ST1基因c.608C>T(p.Thr203Met)杂合突变,均符合ACMG致病性突变,生物学预测有害。结论垂体柄阻断综合征临床上以患儿身高增长缓慢最为常见,多表现为联合垂体功能减退,全外显子测序有利于发现致病性突变。 Objective To analyze the characteristics of childhood pituitary stalk interruption syndrome(PSIS) and genetic etiology. Method Patients initially diagnosed as PSIS during January 2016 and March 2018 in the Department of Endocrinology of Capital Institute of Pediatrics Affiliated Children Hospital were retrospectively studied. Whole-exome capture and NGS were performed in all the patients mentioned above, standard interpretation according to ACMG guideline. Result 16 PSIS cases were recruited, the diagnostic age was 1.7- 16.2 years, 11 patients were male, 5 patients were female, 4 patients had breech presentation. 11 patients presented growth retardation, 4 patients presented seizure afebrile. All of the 16 patients were identified with growth hormone deficiency, 15 patients were identified with pituitary hypothyroidism, 11 patients were identified with secondary adrenal insufficiency. A ROBO1 mutation (c.1690C >T, p.Pro564Ser) was found in a 4.9 year male patient, a HS6ST1 mutation (c.608C >T, p.Thr203Met) was found in a 12.3 year female patient. Both of the two mutations were predicted to be deleterious substitutions for protein function. Conclusion Main complaints of patients with PSIS are decreasing growth velocity, such patients usually manifest combined pituitary hormone deficiency, whole-exome sequencing is applied to find causative mutations.
作者 刘子勤 宋福英 邱明芳 钱晔 杜牧 高亢 董倩 陈晓波 LIU Zi-qin;SONG Fu-ying;QIU Ming-fang;QIAN Ye;DU Mu;GAO Kang;DONG Qian;CHEN Xiao-bo(Department of Endocrinology, Capital Institute of Pediatrics Affiliated Children Hospital, Beijing 100020, China)
出处 《中国医刊》 CAS 2019年第1期53-57,共5页 Chinese Journal of Medicine
基金 首都儿科研究所方向性引导基金(FX-2017-03)
关键词 垂体柄阻断综合征 多发垂体功能减退 全外显子测序 Pituitary stalk interruption syndrome Combined pituitary hormone deficiency Whole-exome sequencing
  • 相关文献

参考文献6

二级参考文献71

  • 1赵明,王晓,张忠军.垂体柄中断综合征一例[J].中华内分泌代谢杂志,2005,21(3):280-280. 被引量:14
  • 2刘影,李传福,张杨,孟祥水,侯金文,张凯,郑金勇,丛培新.垂体柄阻断综合征的MRI诊断[J].中华放射学杂志,2006,40(3):324-325. 被引量:40
  • 3张国安 安瑞馥等.垂体柄阻断综合征的MR表现及与临床意义的相关性研究.中外健康文摘,2009,.
  • 4田静,王光彬,李桂梅,谢蓉蓉.垂体柄阻断综合征的MRI诊断[J].实用放射学杂志,2007,23(9):1153-1154. 被引量:9
  • 5Tauber M, Chevrel J, Diene G, et al. Long-term evolution of endo- crine disorders and effect of GH therapy in 35 patients with pituitary stalk interruption syndrome [ J ]. Horm Res,2005,64 ( 6 ) :266-273.
  • 6eqijayanand P, Mahadevan S, So Shivbalan, et al. Pituitary stalk in- terruption syndrome [ J ]. Indian Journal of Pediatrics, 2007,74 (9) : 874-875.
  • 7Arrigo T, Wasniewska M, De Luca F, et al. Congenital adenohy- pophysis aplasia: Clinical features and analysis of the transcriptional factors for embryonic pituitary development[ J]. J Endocrinol Invest, 2006,29 ( 3 ) :208-213.
  • 8Turton JP, Mehta A, Raza J, et al. Mutations within the transcription factor PROP1 are rare in a cohort of patients with sporadic combined pituitary hormone deficiency (CPHD) [ J]. Clin Endocrino, 2005, 63(1) :10-18.
  • 9Rottembourg D, Linglart A, Adamsbaum C, et al. Gonadotrophic status in adolescents with pituitary stalk interruption syndrome [ J]. Clin Endocrinol 2008,69 : 105-111.
  • 10El Chehadeh S, Bensignor C, de Monlon JV, et al. The pituitary stalk interruption syndrome: endocrine features and benefits of growth hormone therapy [ J ]. Ann Endocrino1,2010,71 : 102-110.

共引文献23

同被引文献36

引证文献3

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部